Schapendoes
The tested variant with the highest allele frequency is Chondrodystrophy and Intervertebral Disc Disease Risk, at 48% among the 45 Schapendoess tested (Donner 2023; gene copies, not dogs), then Hyperuricosuria (20%) and Protein Losing Nephropathy (3.3%).
Which disease variants turn up in Schapendoess?
From a panel of 250 Mendelian-disease variants screened in 1,054,293 dogs (Donner et al. 2023), 4 turn up in Schapendoess at observable frequency. The figure beside each is its allele frequency. Of the gene copies tested in this breed, the share that carry the variant. Every dog carries two copies, so this is not the share of dogs. It is not clinical risk. Most recessive variants require two copies for disease expression; many dominant variants show incomplete penetrance. Read this as a population fingerprint of what's in the gene pool, not a per-dog prediction.
FGF4what this gene does
FGF4 influences leg length by affecting bone growth, leading to shorter legs in certain breeds.
For your dog: If your dog is from a breed known to carry this gene, it's worth discussing spinal health with your vet, but being a carrier doesn’t guarantee problems.
SLC2A9what this gene does
SLC2A9 is a gene that helps regulate uric acid levels in a dog's body. It plays a role in how the kidneys handle this substance.
For your dog: If your dog is one of the breeds known to carry this gene variant, it’s worth discussing with your vet to understand any potential urinary health concerns.
PDK4what this gene does
PDK4 helps regulate how cells use energy, especially in the heart muscle.
For your dog: If your dog is one of the breeds known to carry this gene, it’s worth discussing heart health with your vet, but being a carrier doesn’t mean your dog will develop disease.
NPHS1what this gene does
NPHS1 is a gene important for kidney function, helping to keep proteins in the blood where they belong.
For your dog: If your dog’s breed is on the list, it’s worth asking your vet about NPHS1 to understand any risks and keep an eye on kidney health.
What these results mean for a Schapendoes
47.8% of Schapendoess in the Donner 2023 cohort carried it (n=45).
- Two extra copies of a growth gene, FGF4, shape dog legs and spines. The one on chromosome 12 is the one tied to disc disease; the one on chromosome 18 shortens legs.
OMIA 000157-9615
“Two FGF4 retrogenes (FGF4L1 on chromosome 18 and FGF4L2 on chromosome 12) have been identified to cause dwarfism across many dog breeds.” OMIA 000157-9615
“Brown et al. (2017) reported that an FGF4 retrogene insertion in chromosome CFA12” OMIA 000157-9615
- Carrying it raises risk. It does not say which dog will have a disc problem. In Dachshunds researchers found the test is not a valid risk indicator on its own.
OMIA 000157-9615
“the FGF4 retrogene insertion on CFA12 is not a valid risk indicator on its own” OMIA 000157-9615
What to do
Ask your veterinarian what a carrier result changes for your dog. What lowers risk in a carrier is not established in the sources this page draws on.
No test, or a mix
Without a test nobody can say whether a dog carries it. Leg length alone does not tell you: the disc-disease copy and the short-leg copy are different insertions.
5.6% of Schapendoess in the Donner 2023 cohort carried it (n=45).
- This is a marker, not an established cause. The curated record says a test based on it is not a good indicator of heart disease risk even in Dobermans, the breed it was found in.
OMIA 000162-9615
“it is evident that any DNA test based on this marker will not be a good indicator of liability to this disorder in Dobermans” OMIA 000162-9615
What to do
A carrier result for this marker is not, on its own, a reason for heart screening. Heart screening is a conversation with your veterinarian about the breed and the dog.
No test, or a mix
What this marker means in breeds other than the Doberman is not established in the sources this page draws on.
For researchers Population genetics, disease models and every recorded condition Open the research detail for the Schapendoes
Where every number on this page came from.
This page draws on one primary data source. Allele frequencies and sample sizes come from Donner et al. 2023 (CC-BY-4.0), a direct-to-consumer screening cohort, graded Limited as a study design because the dogs were tested at their owners' choice. No genotyped research dogs of this breed are in the three open releases the atlas reads, so the population-genetic sections other breed pages carry are absent here for that reason, not hidden. Conditions recorded for the breed come from OMIA.
What this page does not yet have. Inheritance modes and per-disease penetrance evidence from Donner 2023 are in the structured data for every variant the panel covers. Mondo, OMIM, Ensembl, and HGNC cross-references live on the gene and disease pages this page links to, rather than being repeated here. What is still absent from this breed page is anything not in the cited panel, and each such gap carries its cause where it appears.
How to cite this page. Cite Donner et al. 2023 (doi:10.1371/journal.pgen.1010651) for every frequency on this page, and OMIA for each condition, with the sample size shown beside the figure.
Some things about living with a schapendoes never make it into a database. Add what you know as a Keeper, in your words →
Lived experience, kept beside the science.No schapendoess are in the atlas yet. Yours would be the first star for the breed.
Every schapendoes added sharpens the breed's genetic neighborhood. Enrollment is free. The data stays open. The star is permanent.
- Donner J, Freyer J, Davison S, Anderson H, Blades M, Honkanen L, et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651. doi:10.1371/journal.pgen.1010651
- Brundage DM (2026). CanVAS: A Harmonized and Imputed Canine Variant Atlas. bioRxiv. doi:10.64898/2026.04.13.718238
- Nicholas, F.W., Tammen, I., & Sydney Informatics Hub. (2026). Online Mendelian Inheritance in Animals (OMIA) [dataset]. The University of Sydney. https://omia.org. doi:10.25910/2AMR-PV70 (retrieved April 2026).